Home/Specialties/Gynaecology & Maternity Surgery

Practice · Gynaecology & Maternity Surgery

A women-centred intake engine your OBGYN team will endorse.

We build referring-obstetrician, GP and second-opinion pathways for high-risk obstetrics, laparoscopic gynaecology and pelvic reconstruction — with communication designed around informed choice, not funnels.

For Chiefs of Obstetrics & Gynaecology, Maternity Program Directors and MDs of women & child super-specialties.

Request a Gynae & Maternity Pipeline Blueprint →Review case evidence

High-Risk Referrals

+168%

12-month cohort

Laparoscopic Case Mix

74%

of hysterectomy volume

OBGYN Referral MOUs

signed in metro catchment

OT Utilization

82%

gynae + obstetric block

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

High-Risk Obstetrics / MFM

₹1.8 L–4.5 L

Antenatal high-risk referral pathway

Laparoscopic Hysterectomy

₹1.4 L–2.8 L

Fibroid & AUB surgical funnel

Endometriosis Surgery

₹1.6 L–3.2 L

Chronic-pelvic-pain second-opinion

Pelvic Floor Reconstruction

₹1.8 L–3.5 L

POP & incontinence pathway

Gynae-Oncology (with Onco)

₹3.5 L–8.0 L

Diagnostic-report tumor-board funnel

Fertility & IVF Adjunct

₹1.4 L–3.5 L / cycle

Long-cycle fertility-workup funnel

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

2.4× high-risk obstetric admissions, 74% laparoscopic hysterectomy mix.

A representative RDV engagement in the Gynaecology & Maternity Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: Women & child super-specialty, 140 beds, Tier-1 metro
Duration: 12 months
Cohort: n = 2,140 OBGYN-referred cases
Outcome: 2.4× high-risk obstetric admissions, 74% laparoscopic hysterectomy mix

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Gynae & Maternity choose RDV

Trust is earned in the operating logic, not the pitch deck.

Informed-choice communication

Every asset presents surgical options, alternatives and risks. No coercive funnels — women decide, then choose you.

OBGYN referrer primacy

Gynae growth flows through referring OBGYNs. MOU network is the primary demand engine, media is supporting.

PCPNDT-safe imaging workflow

Antenatal imaging content reviewed against PCPNDT norms. Zero sex-determination adjacency.

Pelvic-floor MDT integration

Uro-gynae + colorectal + physio MDT for POP and incontinence, generating multi-department revenue attribution.

From an engagement

"The OBGYN MOU network changed the referral map for high-risk cases in the region. Our MFM team's calendar filled without a single ad campaign for maternity."

— Chief of Obstetrics & Gynaecology · 140-bed women & child unit

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Gynae & Maternity Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

MFM specialist high-risk decision framework
Laparoscopic gynae surgeon technique library (co-authored)
Pelvic-floor MDT (uro-gynae + colorectal + physio) protocol

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — no fertility-outcome guarantees
PCPNDT-safe imaging & counselling protocols
Woman-consent-first content and imagery workflow

Catchment note: Metropolitan OBGYN networks plus Tier-2 high-risk-obstetric referral corridors.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Gynae & Maternity.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
Gynae & obstetric OT audit; case-source teardown.
Week 2
OBGYN, GP and MFM referrer catchment mapping.
Week 3
Procedure economics; pelvic-floor MDT revenue model.
Week 4
Founder-led blueprint with Chief of OBGYN.

Where we compound

The unfair edge — for Gynae & Maternity specifically.

OBGYN MOU network at 60+ signed practices per metro
PCPNDT-safe content workflow — differentiator in maternity category
Pelvic-floor MDT attribution model — cross-department revenue capture

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

Maternity marketing has become a race to the bottom.

Which is why we don't compete on package pricing. We compete on high-risk clinical capability and OBGYN referrer trust. Different funnel, different economics.

PCPNDT compliance risk is high.

Handled by workflow, not policy alone. Zero antenatal imagery in campaigns, no sex-related messaging adjacency, quarterly internal audit.

Our elective gynae is already saturated.

Then we shift focus to complex laparoscopic and pelvic-floor programmes — higher margin, less crowded, more clinical differentiation.

FAQ

The questions Chiefs of Gynae & Maternity ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

How do you handle PCPNDT-sensitive content?+

Zero antenatal imagery, no sex-determination adjacency, quarterly internal audit and legal counsel review of every maternity asset before publication.

Can you build OBGYN MOU networks?+

Yes — this is our primary maternity engine. Signed value exchanges include joint MFM case discussion, outcome tracking and co-authored patient education.

What about IVF & fertility programmes?+

Long-cycle referral funnel. We build fertility-workup pathways that convert to IVF over 6–9 months, with realistic outcome-neutral communication.

Next step